A recombinant pseudorabies virus expressing TgSAG1 protects against challenge with the virulent Toxoplasma gondii RH strain and pseudorabies in BALB/c mice.
暂无分享,去创建一个
L. Shang | Quan Liu | Xing-Quan Zhu | J. Men | Rongliang Hu | Zhiping Xia | Zedong Wang | Shengyan Gao | Xichen Zhang | Y. Zhai | Li Jiang
[1] Quan Liu,et al. Immune response induced by recombinant Mycobacterium bovis BCG expressing ROP2 gene of Toxoplasma gondii. , 2007, Parasitology international.
[2] B. Liu,et al. Toxoplasma gondii antibodies in cancer patients. , 2007, Cancer letters.
[3] Huanchun Chen,et al. A recombinant pseudorabies virus co-expressing capsid proteins precursor P1-2A of FMDV and VP2 protein of porcine parvovirus: a trivalent vaccine candidate , 2007, Biotechnology Letters.
[4] M. Igarashi,et al. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice , 2007, Parasitology.
[5] Y. Li,et al. Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice , 2007, Parasitology Research.
[6] B. Li,et al. Immunogenicity and protective efficacy of recombinant pseudorabies virus expressing the two major membrane-associated proteins of porcine reproductive and respiratory syndrome virus. , 2007, Vaccine.
[7] E. Innes,et al. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora , 2006, Parasitology.
[8] X. Ren,et al. Assembly of pseudorabies virus genome-based transfer vehicle carrying major antigen sites of S gene of transmissible gastroenteritis virus: Potential perspective for developing live vector vaccines , 2006, Biologicals.
[9] R. Gazzinelli,et al. Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice. , 2006, Human gene therapy.
[10] Xuehui Cai,et al. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets. , 2005, Veterinary immunology and immunopathology.
[11] A. Reyes-Sandoval,et al. Recombinant viruses as vaccines against viral diseases. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[12] J. Montoya,et al. Toxoplasmosis , 2004, The Lancet.
[13] Huanchun Chen,et al. Construction of recombinant pseudorabies virus expressing NS1 protein of Japanese encephalitis (SA14-14-2) virus and its safety and immunogenicity. , 2004, Vaccine.
[14] R. Rosales,et al. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis , 2004, Parasitology.
[15] S. Xiao,et al. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprotein C of pseudorabies virus in mice. , 2004, Vaccine.
[16] C. Hengartner,et al. Complete, Annotated Sequence of the Pseudorabies Virus Genome , 2004, Journal of Virology.
[17] G. M. Bhopale. Development of a vaccine for toxoplasmosis: current status. , 2003, Microbes and infection.
[18] J. Lannes-Vieira,et al. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. , 2003, Vaccine.
[19] K. Fujisaki,et al. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats , 2002, Parasitology Research.
[20] R. Gibbs,et al. Congenital Toxoplasmosis: A Review , 2001, Obstetrical & gynecological survey.
[21] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[22] L. Weiss,et al. Toxoplasma gondii: from animals to humans. , 2000, International journal for parasitology.
[23] D. Bout,et al. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. , 2000, Vaccine.
[24] R. Weigel,et al. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. , 1999, The Journal of parasitology.
[25] N. de Wind,et al. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity. , 1994, Virology.
[26] A. Capron,et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. , 1992, Journal of immunology.
[27] T. Foulon,et al. Rapid detection of pseudorabies virus genomic sequences in biological samples from infected pigs using polymerase chain reaction DNA amplification. , 1990, Veterinary microbiology.
[28] A. Salwa. A natural outbreak of Aujeszky's disease in farm animals. , 2004, Polish journal of veterinary sciences.
[29] G. Chang,et al. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2 , 2003, Parasitology Research.
[30] H. Sambrook. Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .
[31] D. R. Thomsen,et al. Pseudorabies virus as a live virus vector for expression of foreign genes. , 1987, Gene.